NCI-H719 [H719] (ATCC® CRL-5837™) Organism: Homo sapiens, human / Tissue: lung / Disease: stage E,carcinoma; classic small cell lung cancer General Information Characteristics Culture Method Specifications History Documentation Print Email Share Share this product Facebook Twitter Google+ Permits and Restrictions View Restrictions Organism Homo sapiens, human Tissue lung Product Format frozen Culture Properties suspension Biosafety Level 1 Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. Disease stage E,carcinoma; classic small cell lung cancer Age 55 years Gender female Ethnicity Caucasian Applications The line was established in April 1984. Images Derivation The line was established in April 1984. Clinical Data The patient was a smoker.femaleCaucasian55 years Comments The line was established in April 1984.The patient was a smoker.100 pack years. Complete Growth Medium HITES medium supplemented with 5% fetal bovine serumThe base medium for this cell line is ATCC-formulated DMEM:F12 Medium Catalog No.30-2006. To make the complete growth medium,add the following components to the base medium 0.005 mg/ml Insulin 0.01 mg/ml Transferrin 30nM Sodium selenite (final conc.) 10 nM Hydrocortisone (final conc.) 10 nM beta-estradiol (final conc.) extra 2mM L-glutamine (for final conc. of 4.5 mM) 5% fetal bovine serum (final conc.) Cryopreservation Culture medium, 95%; DMSO, 5% Culture Conditions Temperature: 37.0°C STR Profile Amelogenin: XCSF1PO: 10,11D13S317: 12D16S539: 9D5S818: 13D7S820: 10THO1: 8,9TPOX: 8,11vWA: 16,18 Name of Depositor AF Gazdar, JD Minna Deposited As Homo sapiens Year of Origin 1984 References NCI-Navy Medical Oncology Branch Cell Line Supplement. J. Cell. Biochem. suppl. 24: 1996. Basic Documentation Product Sheet Certificate of Analysis SDS Other Documentation Cell Micrograph p53 Hotspot Mutation Data Restrictions The line is available with the following restrictions: This cell line was deposited at the ATCC by Dr. Adi F. Gazdar and is provided for research purposes only. Neither the cell line nor products derived from it may be sold or used for commercial purposes. Nor can the cells be distributed to third parties for purposes of sale, or producing for sale, cells or their products. The cells are provided as service to the research community. They are provided without warranty of merchantability or fitness for a particular purpose or any other warranty, expressed or implied. Any proposed commercial use of the these cells, or their products, must first be negotiated with the National Cancer Institute (NCI). For further information, please contact NCI’s Technology Transfer Center at NCI_TTC_Contact@mail.nih.gov or by phone at (240)-276-5514. References NCI-Navy Medical Oncology Branch Cell Line Supplement. J. Cell. Biochem. suppl. 24: 1996.